Modulation of novel DNA adducts during human uterine cervix cancer progression

International Journal of Oncology

Volumn 29, Issue 6, 2006, Pages 1437-1443

  Ravoori, Srivani ^a   Vadhanam, Manicka V ^a   Davey, Diane D ^b   Srinivasan, Cidambi ^c   Nagarajan, Bala ^d   Gupta, Ramesh C ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d CANCER INSTITUTE WIA   (India)

Author keywords

Cervical cancer; DNA adducts; Inflammation; Oxidative DNA damage

Indexed keywords

DNA; REACTIVE OXYGEN METABOLITE;

ARTICLE; DISEASE COURSE; DNA ADDUCT; FEMALE; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PATHOLOGY; THIN LAYER CHROMATOGRAPHY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CHROMATOGRAPHY, THIN LAYER; DISEASE PROGRESSION; DNA ADDUCTS; DNA, NEOPLASM; FEMALE; HUMANS; REACTIVE OXYGEN SPECIES; UTERINE CERVICAL NEOPLASMS;

EID: 38349100411     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.6.1437     Document Type: Article

References (39)

1. Marnett LJ: Oxyradicals and DNA damage. Carcinogenesis 21: 361-370, 2000.
2. Jaiswal M, La Russo NF, Burgart LJ and Gores GJ: Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 60: 184-190, 2000.
3. Salvemini D and Cuzzocrea S: Superoxide, superoxide dismutase and ischemic injury. Curr Opin Investig Drugs 3: 886-895, 2002.
4. Halliwell B and Aruoma OI: DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett 281: 9-19, 1991.
5. Gupta RC and Lutz WK: Background DNA damage for endogenous and unavoidable exogenous carcinogens: a basis for spontaneous cancer incidence? Mutat Res 424: 1-8, 1999.
6. Marnett LJ and Burcham PC: Endogenous DNA adducts: potential and paradox. Chem Res Toxicol 6: 771-785, 1993.
7. Nair J, Barbin A, Velic I and Bartsch H: Etheno DNA-base adducts from endogenous reactive species. Mutat Res 424: 59-69, 1999.
8. Chung FL, Nath RG, Nagao M, Nishikawa A, Zhou GD and Randerath K: Endogenous formation and significance of 1,N2-propanodeoxyguanosine adducts. Mutat Res 424: 71-81, 1999.
9. Marnett LJ: Chemistry and biology of DNA damage by malondialdehyde. IARC Sci Publ 150, pp17-27, 1999.
10. Follen M and Schottenfeld D: Surrogate endpoint biomarkers and their modulation in cervical chemoprevention trials. Cancer 91: 1758-1776, 2001. (Pubitemid 32377963)
11. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
12. Wyatt SW, Lancaster M, Bottorff D and Ross F: History of tobacco use among Kentucky women diagnosed with invasive cervical cancer: 1997-1998. J Ky Med Assoc 99: 537-539, 2001.
13. Walboomers JM, Jacobs MV, Manos MM, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19, 1999. (Pubitemid 29406813)
14. Ostor AG: Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12: 186-192, 1993.
15. Castellsague X, Bosch FX and Munoz N: Environmental co-factors in HPV carcinogenesis. Virus Res 89: 191-199, 2002.
16. Castle PE, Hillier SL, Rabe LK, et al: An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 10: 1021-1027, 2001.
17. Tjiong MY, van der Vange N, ten Kate FJ, et al: Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. Gynecol Oncol 73: 285-291, 1999.
18. Srivani R and Nagarajan B: A prognostic insight on in vivo expression of interleukin-6 in uterine cervical cancer. Int J Gynecol Cancer 13: 331-339, 2003.
19. Srivani R, Pratibha K, Selvaluxmy G and Nagarajan B: Molecular logistics of cytokines in cervical cancer. Curr Sci 84: 434-438, 2003.
20. 32P-Postlabeling for detection of DNA adducts. In: Technologies for detection of DNA damage and mutations. Pfeifer GP (ed.) Plenum Press, New York, pp45-61, 1996.
21. 32)P-postlabeling assay for the sensitive detection of 8-oxodeoxyguanosine in tissue DNA. Chem Res Toxicol 14: 951-957, 2001.
22. McCullagh P and Nelder JA: Generalized Linear Models. Chapman & Hall Inc., 1989.
23. Phillips DH, Schoket B, Hewer A and Grover PL: Human DNA adducts due to smoking and other exposures to carcinogens. Prog Clin Biol Res 340C: 283-292, 1990.
24. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001.
25. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002.
26. Mantovani A: Cancer: inflammation by remote control. Nature 435: 752-753, 2005.
27. De Visser KE, Korets LV and Coussens LM: De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7: 411-423, 2005.
28. Zavros Y, Eaton KA, Kang W, et al: Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma. Oncogene 24: 2354-2366, 2005.
29. Nickoloff BJ, Ben-Neriah Y and Pikarsky E: Inflammation and cancer: is the link as simple as we think? J Invest Dermatol 124: x-xiv, 2005.
30. Singer B and Hang B: What structural features determine repair enzyme specificity and mechanism in chemically modified DNA? Chem Res Toxicol 10: 713-732, 1997.
31. Phillips DH and She MN: DNA adducts in cervical tissue of smokers and non-smokers. Mutat Res 313: 277-284, 1994.
32. Plummer M, Herrero R, Franceschi S, et al: Smoking and cervical cancer: pooled analysis of the IARC multi-centric case - control study. Cancer Causes Control 14: 805-814, 2003.
33. Melikian AA, Sun P, Prokopczyk B, et al: Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry. Cancer Lett 146: 127-134, 1999.
34. Li E, Beard C and Jaenisch R: Role for DNA methylation in genomic imprinting. Nature 366: 362-365, 1993.
35. Das PM and Singal R: DNA methylation and cancer. J Clin Oncol 22: 4632-4642, 2004.
36. Davis CD and Uthus EO: DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med 229: 988-995, 2004.
37. Thun MJ, Henley SJ and Calle EE: Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene 21: 7307-7325, 2002.
38. Phillips DH: Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 23: 1979-2004, 2002.
39. Wright TC Jr and Schiffman M: Adding a test for human papillomavirus DNA to cervical-cancer screening. N Engl J Med 348: 489-490, 2003.